Neogen beats

 

Neogen tops Q4 FY26 estimates with adjusted EPS $0.09 on $225.3M sales, reiterates FY27 revenue guidance of $880–$885M

• Quarterly results beat Zacks consensus estimates on both earnings per share and revenue.
• Neogen reported a Q4 FY26 net loss of $11.3 million.
• Core revenue growth in Q4 FY26 was 4.3% for the period.
• For FY27, Neogen guides adjusted EBITDA in a range of $180–$182 million.

https://finviz.com/stock?t=NEOG&p=d